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INTRODUCTION
Syncope is a very common symptom and it repre-
sents an important public health problem because it
leads to traumatic lesions, worsens quality of life; it is
one of the most common causes of inability and it is as-
sociated with elevated health care costs (1, 17). Syn-
cope is defined as a sudden and transitory loss of con-
sciousness and orthostatic position associated with a
fast, spontaneous and complete regain of conscious-
ness. The loss of consciousness derives from the re-
duction in cerebral blood flow.
Lypotimia is defined as a sudden weakness, incapac-
ity to maintain the orthostatic position, visus block out
and near loss of consciousness. It can precede the syn-
copal episode or not (2).
Vasovagal syncope is the most common cause of
syncope and it represents about 10-40% of all the caus-
es (19). Vasovagal syncope physiopathology: when we
step over from the clinostatic to orthostatic position
about 800 ml of blood goes into the subdiaphragmatic
part of the body with a reduction in preload into the right
ventricle. In patients with vasovagal syncope the
mechanoceptors located in the heart and in the carotid
bulb send an exaggerated signal to the cerebral trunk
with an alterated sympathovagal response and vasode-
pression (3).
The head-up tilt test (HUTT) is the most efficacious
test in studying the vasovagal reaction. In addition, ECG
monitoring is very important in discovering the cause of
syncope both with traditional ECG 24-hr and the R-test,
and with ECG monitoring over a period of 7 days.
The aim of our study was to verify the diagnostic val-
ue of the HUTT in patients suspected of vasovagal syn-
drome and of the R-test in patients with unexplained
syncope.
Subjects and methods
In our syncope unit, from 2002-2005, there were 211
patients symptomatic for syncope and/or lypotimia sus-
picious for vasovagal syndrome. Mean age was 41.5 yrs
(range 18-65 yrs); 88 patients were male and 123 were
female. Fifty-eight patients had one or more lypotimic
episodes in anamnesis and 153 patients had one or
more syncopal episodes. Some patients had already
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undergone other diagnostic tests for syncope such as
Holter ECG monitoring, echocardiogram, electrophysi-
ological study, electroencephalogram, encephalic CT,
and upper aortic trunk Doppler. All patients candidates
for HUTT underwent carotid sinus massage with nega-
tive responses. After a detailed description of the test
modality, the patients had to give their informed con-
sent. Some general measures were respected when tilt
testing was performed. The room where the test is per-
formed should be quiet and with dim lighting. Patients
should fast for at least 2 hr before the test. 
In order to monitor arterial blood pressure (BP), we
adopted the F500 system, a versatile non-invasive
beat-to-beat monitoring system. It captures the con-
tinuous BP waveform, and automatically computes up
to 15 important beat-to-beat hemodynamic parame-
ters including cardiac output (CO), stroke volume
(SV), total peripheral resistance (TPR), pulse rate vari-
ability (PRV) and baroreflex sensitivity (BRS). ECG
monitoring at 25 mm/sec in 12 derivations is obtained
in the basal position after the supine position phase,
every 3 min and every time it was necessary. We used
a tilt table with a foot board support to achieve the up-
right position smoothly and rapidly, and to reset the
supine position quickly (<10 sec) when the test is
completed to avoid the consequences of a prolonged
loss of consciousness. One physician was present
throughout the tilt test procedure. We followed the
“Italian Protocol”. 
This protocol provides a supine pre-tilt phase of at
least 5 min when no venous cannulation is performed
and at least 20 min when cannulation is undertaken; tilt
angle is 60-70°. Passive phase is a minimum of 20 min
and a maximum of 45 min. If the passive phase has
been negative 400 µg of nitroglicerin spray is used sub-
lingually; the drug challenge phase is about 15-20 min.
The end-point of the test is defined as the induction of
syncope or a progressive and symptomatic fall in BP for
at least 3 min or until a value of 60 mmHg in systolic BP
is achieved or the completion of the planned duration of
tilt including drug stimulation (15, 16, 18).
Hemodynamic results of HUTT
￿ Type 1 mixed response: heart rate falls at the time of
syncope but the ventricular rate does not fall to <40
beats/min or falls to <40 beats/min for <10 sec with or
without asystole of <3 sec. BP falls before the heart
rate falls.
￿ Type 2A cardio inhibition without a systole: heart rate
falls to a ventricular rate <40 beats/min for >10 sec,
but asystole of >3 sec does not occur. BP falls before
the heart rate falls.
￿ Type 2B cardio inhibition with a systole: a systole oc-
curs for >3 sec. BP fall coincides with or occurs before
the fall in heart rate.
￿ Type 3 vasodepressor: heart rate does not fall >10%
from its peak at the time of syncope.
Forty-five patients with syncope and a negative re-
sponse to HUTT, after a negative 24-hr Holter ECG, un-
derwent an ECG ambulatory registration with the R-test
that registers ECG over a period of 7 days, and to give
an analysis with dedicated software for specific event
monitoring. 
The R-test (Evolution Novacor-Cardioline) is a com-
pact and lightweight ergonomic recorder (45 g batteries
included, 60 x 48 x 28 mm) suspended around the neck
like a medallion; it is maintained by an auto-adjustable
cable, a particularly ergonomic configuration which
drastically limits movement artefacts; its advanced
miniaturized electronics are capable of real time QRS
acquisition and processing.
It stores only significant events; therefore, avoiding
the generation of huge data files usually associated with
long-term ECG monitoring. The number and type of
events recorded, as well as the pre- and post-event
time are entirely programmable, allowing either specific
screening for the confirmation of a suspected pathology
or a wider search field in the absence of strong clinical
evidence. Voluntary registration is possible during the
specific symptom; in addition, this recorder includes a
pre- and a post-registration of specific events. 
The R-test evolution is equipped with a new acquisi-
tion system favoring the CM5 lead, for excellent results
in arrhythmia detection and ST shift measurement in
case… The user interface on PCs (RTSoft) is a model of
user friendliness. Patient id is directly sent to and stored
in the recorder before it starts, for enhanced data treat-
ment safety. Transfer of the recorded data, display of all
the events as well as the heart rate curve and event his-
tograms are immediate, allowing a global overview.
Each strip can also be zoomed in on separately for a de-
tailed analysis.Raddino et al
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RESULTS
Among the patients, 113 were positive to the HUTT
and 98 were negative. In the positive group, 87 were fe-
males and 26 were males (median age 32 ± 10 yrs),
while in the negative group 36 were female and 62 were
male (median age 61 ± 10 yrs).
Of the 45 patients who underwent the R-test, five
patients were symptomatic for syncope: in three
cases there was a registration of complete atrial
ventricular block with idio-ventricular rhythm and in
two cases there was evidence of major pauses >3
sec (Fig. 1). All these patients needed pacemaker
implantation.
Among the patients submitted to the R-test, 19 pa-
tients presented with hyper kinetic arrhythmias (seven
patients with ventricular ectopic beats (Fig. 2), five pa-
tients with supra-ventricular ectopic beats, four pa-
tients with short traits of parossistic supra-ventricular
tachycardia and three patients with short traits of atrial
fibrillation) (Figs. 3-7).
DISCUSSION 
Syncope is a syndrome consisting of a relatively
short period of temporary and self-limited loss of con-
sciousness caused by a transient reduction in blood
flow to the brain (most often the result of systemic hy-
potension). Syncope comprises part of a subset of clin-
ical conditions in which loss of consciousness is tran-
sient; other conditions in this group, which are not syn-
cope and should be clearly distinguished from syncope,
include, for example, seizure disorders, post-traumatic
loss of consciousness and cataplexy (4).
Syncope accounts for up to 3% of emergency room
visits and 6% of hospital admissions. The Framingham
Study reported that approximately 3% of individuals
have a syncopal episode during their lives, although
lifetime incidence in the elderly can be as high as 23%.
Mortality is generally low, but can be up to 33% at 1 yr
in patients with a cardiac aetiology (5). The differential
diagnosis is wide. Diagnosis can be made difficult by
the intermittent nature of the symptoms, the large num-
Fig. 1 - R-test: results for 
hypokinetic arrhythmias.
Fig. 2 - R-test: results for 
hyperkinetic arrhythmias.Diagnostic value of the head-up tilt test and the R-test in patients with syncope
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Fig. 3 - Sinusal pauses (5.7
sec) with syncope.
Fig. 4 - Ventricular ectopic
beat (bygeminism).Raddino et al
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ber of potential aetiologies, and the lack of a gold stan-
dard for clinical investigation. The cost of the investiga-
tion of recurrent unexplained syncope can be high, par-
ticularly if a relatively benign cause of syncope is over-
looked in the process of excluding life-threatening dis-
orders. Recurrences are common after the index event,
occurring in up to one-third of patients. The search for
an underlying cause in patients with syncope often pos-
es a clinical dilemma and even after extensive evalua-
tion, the specific cause can remain unknown in up to
50% of patients. In selected patients, the diagnostic
yield can be improved with the use of specialized stud-
Fig. 6 - A cardioinhibitory 
result.
Fig. 5 - A pure vasogenic 
result.Diagnostic value of the head-up tilt test and the R-test in patients with syncope
176
ies such as head-up tilt testing. Head-up tilt testing is a
widely accepted tool in the investigation of syncope,
particularly where there is no evidence of structural
heart disease (6).
Initial evaluation with anamnesis, clinical examina-
tion, ECG and BP in clinostatic and orthostatic posi-
tions screens the patients suspected of vasovagal syn-
cope and cardiogenic syncope. With an initial evalua-
tion a neurogenic reflex can be suspected with indica-
tive data and when other syncope causes have been ex-
cluded, independent from tilt-table test results. Patients
with positive tilt-table test results and those with a neg-
ative response (indefinite syncope) have similar charac-
teristics and prognosis, so it seems they belong in the
same population. The key remains in selecting the ap-
propriate patients for each investigation, such as by the
presence of a prodrome of autonomic symptoms in
those with suspected vasovagal syncope (7).
The absence of a gold standard diagnostic test for
vasovagal syncope makes the calculation of the exact
specificity and sensitivity of the tilt test difficult, partic-
ularly in view of the variable methodology used in the
different groups reporting results. The ability of the test
to differentiate patients from healthy controls is
nonetheless established with specificity generally up to
90% and sensitivity ranging between 32% and 85%
with the median closer to the upper number (8).
The diagnostic value of the HUTT in our group of pa-
tients is lower than that in the literature data, possibly
due to the low pre-test probability. More rigorous appli-
cation of the guidelines is necessary to optimize the
usefulness of the HUTT. Recent studies have seen how
a correct and specific anamnesis is able to discover
with a high diagnostic value patients affected by vaso-
vagal syndrome (11, 13). However, the tilt test has a
higher sensibility in young female patients (10).
Sheldon et al (11) tested the sensitivity and specifici-
ty of a preliminary questionnaire about the characteris-
tics of the syncopal episodes and every question was
assigned a positive or negative score. The final score
was indicative for vasovagal syncope or not. The point
score correctly classified 90% of patients, diagnosing
vasovagal syncope with 89% sensitivity and 91%
specificity; so it is true that a targeted anamnesis could
make a diagnosis without the tilt test (14).
The availability of implantable cardiac loop recorders is
a significant advance in helping to clarify the situation in
patients with unexplained syncope (9). Not unsurprisingly,
many patients have been found to have a diagnosis differ-
ent from that presumed from their history and other inves-
tigations as evidenced in the ISSUE-2 study. The ISSUE-
2 study with the early application of a loop recorder in pa-
tients with unexplained syncope demonstrated that in a
minority of patients during syncope recurrences there are
tachy or bradyarrhythmias, supraventricular or ventricular
that are responsible for syncopal episodes. 
Fig. 7 - Normal result.Raddino et al
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In our study, the R-test was able to detect an arrhyth-
mic cause of syncope in some patients with negative
HUTT and negative traditional Holter ECG monitoring.
In our opinion, R-test ECG monitoring for a period of 7
days, with the possibility of repeating the test, could be
a preliminary test to determine the use of the im-
plantable loop recorder in patients with unexplained
syncope. It is a very simple method that also reduces
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